BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

399 related articles for article (PubMed ID: 22153719)

  • 1. Targeting Src family kinases in anti-cancer therapies: turning promise into triumph.
    Zhang S; Yu D
    Trends Pharmacol Sci; 2012 Mar; 33(3):122-8. PubMed ID: 22153719
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of SRC family kinases and receptor tyrosine kinases by dasatinib: possible combinations in solid tumors.
    Montero JC; Seoane S; Ocaña A; Pandiella A
    Clin Cancer Res; 2011 Sep; 17(17):5546-52. PubMed ID: 21670084
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Src kinase inhibitors: promising cancer therapeutics?
    Creedon H; Brunton VG
    Crit Rev Oncog; 2012; 17(2):145-59. PubMed ID: 22471705
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Src inhibitors in breast cancer therapy.
    Hiscox S; Nicholson RI
    Expert Opin Ther Targets; 2008 Jun; 12(6):757-67. PubMed ID: 18479222
    [TBL] [Abstract][Full Text] [Related]  

  • 5. PH006, a novel and selective Src kinase inhibitor, suppresses human breast cancer growth and metastasis in vitro and in vivo.
    Ma JG; Huang H; Chen SM; Chen Y; Xin XL; Lin LP; Ding J; Liu H; Meng LH
    Breast Cancer Res Treat; 2011 Nov; 130(1):85-96. PubMed ID: 21181437
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The role of Src in solid tumors.
    Wheeler DL; Iida M; Dunn EF
    Oncologist; 2009 Jul; 14(7):667-78. PubMed ID: 19581523
    [TBL] [Abstract][Full Text] [Related]  

  • 7. SRC inhibitors as potential therapeutic agents for human cancers.
    Trevino JG; Summy JM; Gallick GE
    Mini Rev Med Chem; 2006 Jun; 6(6):681-7. PubMed ID: 16787379
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Src inhibitors in lung cancer: current status and future directions.
    Rothschild SI; Gautschi O; Haura EB; Johnson FM
    Clin Lung Cancer; 2010 Jul; 11(4):238-42. PubMed ID: 20630825
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Src tyrosine kinase as a chemotherapeutic target: is there a clinical case?
    Chen T; George JA; Taylor CC
    Anticancer Drugs; 2006 Feb; 17(2):123-31. PubMed ID: 16428929
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Src-family tyrosine kinases as therapeutic targets in advanced cancer.
    Gelman IH
    Front Biosci (Elite Ed); 2011 Jun; 3(3):801-7. PubMed ID: 21622091
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Src signaling in cancer invasion.
    Guarino M
    J Cell Physiol; 2010 Apr; 223(1):14-26. PubMed ID: 20049846
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical significance of Src expression and activity in human neoplasia.
    Chatzizacharias NA; Kouraklis GP; Giaginis CT; Theocharis SE
    Histol Histopathol; 2012 Jun; 27(6):677-92. PubMed ID: 22473690
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Novel patented SRC kinase inhibitor.
    Lu XL; Liu XY; Cao X; Jiao BH
    Curr Med Chem; 2012; 19(12):1821-9. PubMed ID: 22414081
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [SRC kinases in tumor therapy].
    Dempke W; Zippel R
    Med Klin (Munich); 2010 Oct; 105(10):711-5. PubMed ID: 20981590
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Current status of SRC inhibitors in solid tumor malignancies.
    Puls LN; Eadens M; Messersmith W
    Oncologist; 2011; 16(5):566-78. PubMed ID: 21521831
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical relevance of targeted interference with Src-mediated signal transduction events.
    Ly QP; Yeatman TJ
    Recent Results Cancer Res; 2007; 172():169-88. PubMed ID: 17607941
    [No Abstract]   [Full Text] [Related]  

  • 17. Src and focal adhesion kinase as therapeutic targets in cancer.
    Brunton VG; Frame MC
    Curr Opin Pharmacol; 2008 Aug; 8(4):427-32. PubMed ID: 18625340
    [TBL] [Abstract][Full Text] [Related]  

  • 18. SRC kinase inhibitors: an update on patented compounds.
    Schenone S; Brullo C; Musumeci F; Radi M; Castagnolo D
    Curr Med Chem; 2011; 18(33):5061-78. PubMed ID: 22050754
    [TBL] [Abstract][Full Text] [Related]  

  • 19. SRC family nonreceptor tyrosine kinases as molecular targets for cancer therapy.
    Johnson FM; Gallick GE
    Anticancer Agents Med Chem; 2007 Nov; 7(6):651-9. PubMed ID: 18045060
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Advances in targeting SRC in the treatment of breast cancer and other solid malignancies.
    Mayer EL; Krop IE
    Clin Cancer Res; 2010 Jul; 16(14):3526-32. PubMed ID: 20634194
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.